Allo - Cancer - Thrombosis (AlloTC)

Assistance Publique - Hôpitaux de Paris

Status: Unknown

Conditions: Venous Thromboembolism; Cancer

Treatments: Other: Setting up a specific care path "AlloTC" for management of TVE in patients with cancer

Study type: Observational

Funder types: Other

Identifiers

NCT03563924

K171103J

Details and patient eligibility

About

Management of venous thromboembolism (VTE) in patients with cancer is complex and require the intervention of many specialized health professionals, in hospital but also at home and during follow-up.

The AlloTC project aims to integrate the management of VTE within the multidisciplinary care pathway of the patient with cancer, in order to improve the management of VTE in patients with cancer: optimize treatments and follow-up with appropriate anticoagulants, monitor the implementation of good clinical practice, promote patient involvement and adherence.

The objective of this monocentric study is to evaluate the efficiency of the integration of the therapeutic management of VTE into a specific management of patient with cancer and to set up a specialized "AlloTC" team that coordinates this course of care.

For that purpose, the management of VTE and outcome of patients with cancer and VTE will be compared between two periods : traditional management and management with the "AlloTC" team.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of cancer or haematological malignancies
• Venous thromboembolism diagnosis (symptomatic or not)

Exclusion criteria

• Life expectancy ≤ 3 months
• Inability to understand or sign consent
• Inability to read or understand the French language

Trial design

100 participants in 2 patient groups

Historical cohort

Description:

Patients with venous thromboembolism and cancer who follow traditional management of venous thromboembolism

AlloTC cohort

Description:

Patients with venous thromboembolism and cancer who follow "AlloTC" specific management. "AlloTC" specific care path way develop a personalized care plan (PPS) and ensure the transmission of data (to all the interlocutors: patients and caregivers) at each step of the patient care path.

Treatment:

Other: Setting up a specific care path "AlloTC" for management of TVE in patients with cancer